Clinical Trials Directory

Trials / Completed

CompletedNCT05701020

Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Human Papilloma virus is the most common sexual infection in women, which can leads to cervical lesion and cervical cancer. Pap test is recommanded in women of 25 years old until 65 years old in order to screen subclinic lesions and improve prognosis. Yet, scientific knowledge about chronic disease showed negative consequences on quality of life. However, no study until now has striven to evaluate the consequences of an abnormal pap test on sexuality in adult women. The aim of this study is to evaluate if an abnormal pap test have an impact on the sexual functions in women because of the anxiety and psychological consequences of the diagnosis

Conditions

Interventions

TypeNameDescription
OTHERquestionnaryIf agreeing to the protocol, ; patients will answered questions about sexual health during the gynecologic consultation

Timeline

Start date
2022-12-13
Primary completion
2023-09-12
Completion
2023-09-12
First posted
2023-01-27
Last updated
2023-09-13

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05701020. Inclusion in this directory is not an endorsement.

Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test (NCT05701020) · Clinical Trials Directory